Highlights:

Trump announces a 100% tariff on all branded and patented pharmaceutical imports starting October 1, 2025.

India exported $8.7 billion worth of pharmaceuticals to the US in FY24, making it highly exposed to the new tariff.

Indian companies supply over 45% of generic medicines and 15% of biosimilars used in the US.

Higher tariffs could lead to drug price increases, potential shortages, and increased healthcare costs for US consumers. - Advertisement -

Trump also imposes tariffs on kitchen cabinets, furniture, and heavy trucks as part of a broader trade push.

Major Indian pharma firms, including Dr. Reddy’s, Sun Pharma, and Aurobindo, earn 30–50% of their revenue from the US market.

US President Trump has announced a 100% tariff on all branded and patented pharmaceutical

See Full Page